ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 716522 Null 0.0454469012959163 0.58413577
NSC 740275 5,6-Dihydro-6-(3-morpholinyl-1-propyl)-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0454469012959163 -0.19274529
NSC 681239 Bortezomib 0.0454469012959173 0.24839123
NSC 720538 2-(6-(2-imidazolino)-2-benzthiazolyl)-5-(4-(2-imidazolino)ph enyl)thiophene dihydrochloride dihydrate 0.0454469012959173 -0.13831299
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 1.1700279103085e-005 0.62611231
NSC 176503 Fastigilin B 1.64013221401437e-005 0.787196
NSC 267461 Nanaomycin 1.87615058013433e-005 0.84099028
NSC 679005 2-Butenedioic acid, 2,2'-(2,4-dioxopyrimidine-1,3-diyl)bis-, tetraethyl ester 2.73683969415351e-006 0.73274577
NSC 329691 HM-4 3.2373342271466e-007 0.74831454
NSC 10660 Null 3.25006101781776e-005 0.25232998
Total:136  Current:133    [First] [Prev] [Next] [Last]